Emil Frei III

Emil Frei III was a towering figure in oncology who co-pioneered combination chemotherapy for childhood acute lymphoblastic leukemia alongside Emil Freireich and James Holland at the NCI in the 1950s and 1960s, transforming a universally fatal disease into one curable in the majority of children. His landmark studies demonstrated that combining multiple chemotherapeutic agents with distinct mechanisms could achieve complete remissions and long-term cures in childhood ALL, establishing the conceptual and practical foundation for modern combination chemotherapy across all cancer types. He later served as physician-in-chief at Dana-Farber Cancer Institute where he built its clinical research programs and mentored generations of oncologists who became leaders in the field. His lifetime of contributions to cancer chemotherapy development and clinical translation made him one of the most consequential figures in 20th century oncology.